Phathom Pharmaceuticals, Inc.

NasdaqGS:PHAT 주식 보고서

시가총액: US$600.4m

Phathom Pharmaceuticals 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

NasdaqGS:PHAT 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
15 Jul 24SellUS$396,699Terrie CurranIndividual33,848US$11.72
15 Jul 24SellUS$50,689Molly HendersonIndividual4,325US$11.72
15 Jul 24SellUS$127,760Azmi NabulsiIndividual10,901US$11.72
09 Apr 24SellUS$4,029,196Takeda Pharmaceutical Company LimitedCompany362,737US$11.94
08 Apr 24SellUS$38,129Molly HendersonIndividual3,435US$11.10
28 Mar 24SellUS$6,435,841Takeda Pharmaceutical Company LimitedCompany602,366US$10.89
22 Mar 24SellUS$153,513Terrie CurranIndividual16,851US$9.11
24 Jan 24SellUS$29,999,994Takeda Pharmaceutical Company LimitedCompany3,703,703US$8.10
19 Jan 24SellUS$48,900Molly HendersonIndividual6,307US$7.75
20 Nov 23SellUS$15,403Molly HendersonIndividual2,127US$7.24

내부자 거래량

내부자 구매: 내부자가 지난 3개월 동안 판매한 것보다 더 많은 주식을 구입했는지 판단하기에는 데이터가 부족합니다.

소유권 분석

PHAT 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
민간 기업18,8490.0233%
개인 내부자2,498,5333.09%
공공 기업2,790,4803.45%
VC/PE 기업21,070,65926%
교육기관54,600,24767.4%

주식의 희석: 지난 해 주주 수는 희석되었으며, 총 발행 주식 수 19.4% 만큼 증가했습니다.

최대 주주

상위 25 주주가 회사의 96.95%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
14.8%
Frazier Life Sciences Management, LP
10,109,279US$88.8m0%3.57%
10.9%
Medicxi Ventures (UK) LLP
7,464,572US$65.5m0%13.51%
10.2%
Jennison Associates LLC
6,993,422US$61.4m19.2%0.04%
5.59%
Invesco Ltd.
3,820,003US$33.5m21.6%0.01%
5.11%
Abingworth LLP
3,496,808US$30.7m0%21.31%
4.57%
BlackRock, Inc.
3,122,570US$27.4m6.7%데이터 없음
4.08%
Takeda Pharmaceutical Company Limited
2,790,480US$24.5m0%데이터 없음
3.94%
The Vanguard Group, Inc.
2,696,323US$23.7m21.9%데이터 없음
3.78%
Ensign Peak Advisors, Inc.
2,581,388US$22.7m15%0.04%
3.76%
Woodline Partners LP
2,573,412US$22.6m227%0.19%
2.87%
New Enterprise Associates, Inc.
1,960,169US$17.2m0%0.79%
2.64%
Avidity Partners Management, L.P.
1,804,493US$15.8m11.4%0.88%
2.49%
Portolan Capital Management, LLC
1,699,918US$14.9m50.4%1.05%
2.37%
Gilder Gagnon Howe & Co. LLC
1,622,883US$14.2m10.2%0.16%
2.2%
Checkpoint Capital, LLC, Asset Management Arm
1,504,307US$13.2m71.9%6.9%
2.12%
OrbiMed Advisors LLC
1,449,073US$12.7m0%0.18%
2.05%
Federated Hermes, Inc.
1,403,638US$12.3m0%0.03%
1.91%
FMR LLC
1,304,114US$11.5m49,000%데이터 없음
1.83%
Decheng Capital LLC
1,250,000US$11.0m47.1%2.31%
1.82%
Strategic Advisers LLC
1,243,191US$10.9m28.9%데이터 없음
1.79%
David Socks
1,220,756US$10.7m0%데이터 없음
1.65%
GW&K Investment Management, LLC
1,126,083US$9.9m87.5%0.08%
1.64%
Catalys Pacific
1,122,572US$9.9m55.5%9.0%
1.48%
683 Capital Management, LLC
1,010,000US$8.9m-27.9%0.89%
1.35%
State Street Global Advisors, Inc.
922,788US$8.1m17.5%데이터 없음